Results 141 to 150 of about 411,749 (186)
Some of the next articles are maybe not open access.

Insulin Detemir

Hospital Pharmacy, 2005
Each month, subscribers to The Formulary Monograph Service receive five to six well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada   +2 more
openaire   +1 more source

A case of lipoatrophy with insulin detemir

Diabetes Research and Clinical Practice, 2008
Lipoatrophy is a rare cutaneous side-effect that can develop at the site of insulin injection. Since the introduction of human recombinant insulin the number of cases has decreased although cases have been reported in association with the use of rapid acting insulin analogues and continuous subcutaneous insulin infusion (CSII), recently one case has ...
María I, Del Olmo   +4 more
openaire   +2 more sources

Insulin Detemir

Drugs of the Future, 2003
null McIntyre, J.A., null Bayes, M.
openaire   +3 more sources

Insulin/Insulin detemir

Reactions Weekly, 2023
openaire   +1 more source

Insulin Detemir

RCSB Protein Data Bank, 2018
Shriya Patel, Shuchismita Dutta
openaire   +2 more sources

[Insulin detemir (NN304)].

Nihon rinsho. Japanese journal of clinical medicine, 2002
A line of evidences has demonstrated that a normalization of blood glucose can prevent or delay diabetic complications. To normalize blood glucose in diabetic patients who require insulin treatment, a tailoring the time-action profile of injected insulin is needed. B29Lys-myristoyl.
openaire   +2 more sources

Home - About - Disclaimer - Privacy